Pseudomonas aeruginosa Clinical Isolates: Antibiogram Profile and Biofilm Formation

R. Shrestha
{"title":"Pseudomonas aeruginosa Clinical Isolates: Antibiogram Profile and Biofilm Formation","authors":"R. Shrestha","doi":"10.35248/2157-7609.20.11.247","DOIUrl":null,"url":null,"abstract":"Background: The gram-negative bacterium, Pseudomonas aeruginosa belongs to a vast genus of obligate aerobic, nonfermenting, saprophytes, which are present in water, soil and on plants. Moreover, P. aeruginosa can be frequently isolated from tap water. In its natural habitat, this organism is endowed with weak pathogenic potential. However, its profound ability to survive on inert materials, its minimal nutritional requirement, tolerance to a wide variety of physical conditions and relative resistance to several antimicrobial agents and antiseptics, contribute enormously to its ecological success and its role as an effective opportunistic pathogen. P. aeruginosa is a notoriously difficult organism to control with antibiotics or disinfectants and has become increasingly recognized as an emerging opportunistic pathogen of clinical relevance. Multi-drug-resistant Pseudomonas aeruginosa (MDRPA) are often isolated from patients suffering from nosocomial infections, particularly those who are admitted to intensive care unit (ICU).[3] Thus, infections caused by P.aeruginosa especially in ICU patients are problematic because the organism apart from being inherently resistant to many drug classes, is able to acquire resistance to many effective antimicrobial drugs and therefore infections caused by P. aeruginosa are frequently life threatening and difficult to treat [4,5] Such multidrug resistance could be due to the slowly growing state of P. aeruginosa in the deeper layers of thick biofilms, which the organism has a tendency to form in many in vivo situations[6] Clinical isolates of Pseudomonas aeruginosa often exhibit multidrug resistance due to their inherent ability to form biofilms. Drug resistance in Pseudomonas aeruginosa is a major clinical problem, especially in the management of patients with nosocomial infections and those who are under indwelling medical devices. The man objective of this study is to evaluate the biofilm forming abilities of the clinical isolates of Pseudomonas aeruginosa and to correlate biofilm formation with multidrug resistance.","PeriodicalId":15537,"journal":{"name":"Journal of Drug Metabolism and Toxicology","volume":"29 1","pages":"1-2"},"PeriodicalIF":0.0000,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Drug Metabolism and Toxicology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.35248/2157-7609.20.11.247","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background: The gram-negative bacterium, Pseudomonas aeruginosa belongs to a vast genus of obligate aerobic, nonfermenting, saprophytes, which are present in water, soil and on plants. Moreover, P. aeruginosa can be frequently isolated from tap water. In its natural habitat, this organism is endowed with weak pathogenic potential. However, its profound ability to survive on inert materials, its minimal nutritional requirement, tolerance to a wide variety of physical conditions and relative resistance to several antimicrobial agents and antiseptics, contribute enormously to its ecological success and its role as an effective opportunistic pathogen. P. aeruginosa is a notoriously difficult organism to control with antibiotics or disinfectants and has become increasingly recognized as an emerging opportunistic pathogen of clinical relevance. Multi-drug-resistant Pseudomonas aeruginosa (MDRPA) are often isolated from patients suffering from nosocomial infections, particularly those who are admitted to intensive care unit (ICU).[3] Thus, infections caused by P.aeruginosa especially in ICU patients are problematic because the organism apart from being inherently resistant to many drug classes, is able to acquire resistance to many effective antimicrobial drugs and therefore infections caused by P. aeruginosa are frequently life threatening and difficult to treat [4,5] Such multidrug resistance could be due to the slowly growing state of P. aeruginosa in the deeper layers of thick biofilms, which the organism has a tendency to form in many in vivo situations[6] Clinical isolates of Pseudomonas aeruginosa often exhibit multidrug resistance due to their inherent ability to form biofilms. Drug resistance in Pseudomonas aeruginosa is a major clinical problem, especially in the management of patients with nosocomial infections and those who are under indwelling medical devices. The man objective of this study is to evaluate the biofilm forming abilities of the clinical isolates of Pseudomonas aeruginosa and to correlate biofilm formation with multidrug resistance.
铜绿假单胞菌临床分离:抗生素谱和生物膜形成
背景:革兰氏阴性细菌,铜绿假单胞菌属于专性需氧,不发酵,腐生菌,存在于水,土壤和植物。此外,铜绿假单胞菌经常可以从自来水中分离出来。在其自然栖息地,这种生物被赋予了弱致病潜能。然而,它在惰性物质上生存的深刻能力,它的最低营养需求,对各种物理条件的耐受性和对几种抗菌剂和防腐剂的相对抗性,极大地促进了它的生态成功和它作为一种有效的机会性病原体的作用。众所周知,铜绿假单胞菌是一种难以用抗生素或消毒剂控制的生物,并且越来越被认为是一种具有临床意义的新兴机会性病原体。耐多药铜绿假单胞菌(MDRPA)通常从医院感染的患者中分离出来,特别是那些住进重症监护病房(ICU)的患者。[3]因此,铜绿假单胞菌(P.aeruginosa)引起的感染,特别是在ICU患者中引起的感染是有问题的,因为这种细菌除了对许多药物具有固有的耐药性外,还能够获得对许多有效的抗菌药物的耐药性,因此铜绿假单胞菌引起的感染经常危及生命且难以治疗[4,5],这种多药耐药可能是由于铜绿假单胞菌在较厚的生物膜的较深层中生长缓慢。这种细菌在许多体内情况下都有形成的倾向[6],铜绿假单胞菌的临床分离株由于其固有的形成生物膜的能力,经常表现出多药耐药。铜绿假单胞菌的耐药性是一个主要的临床问题,特别是在医院感染患者和留置医疗器械患者的管理中。本研究的主要目的是评估铜绿假单胞菌临床分离株的生物膜形成能力,并将生物膜形成与多药耐药性联系起来。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信